BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25585539)

  • 1. MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.
    Lai M; Du G; Shi R; Yao J; Yang G; Wei Y; Zhang D; Xu Z; Zhang R; Li Y; Li Z; Wang L
    Mol Med Rep; 2015 May; 11(5):3301-7. PubMed ID: 25585539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis.
    Yan S; Wang M; Zhao J; Zhang H; Zhou C; Jin L; Zhang Y; Qiu X; Ma B; Fan Q
    Int J Mol Med; 2016 Jul; 38(1):201-9. PubMed ID: 27247228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
    Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
    Do MT; Kim HG; Choi JH; Jeong HG
    Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-34a aggravates coxsackievirus B3-induced apoptosis of cardiomyocytes through the SIRT1-p53 pathway.
    Jiang D; Li M; Yu Y; Shi H; Chen R
    J Med Virol; 2019 Sep; 91(9):1643-1651. PubMed ID: 30968966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.
    Tian XF; Ji FJ; Zang HL; Cao H
    PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-34a repression of SIRT1 regulates apoptosis.
    Yamakuchi M; Ferlito M; Lowenstein CJ
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13421-6. PubMed ID: 18755897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.
    Li L; Yuan L; Luo J; Gao J; Guo J; Xie X
    Clin Exp Med; 2013 May; 13(2):109-17. PubMed ID: 22623155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.
    Ferreira DM; Afonso MB; Rodrigues PM; Simão AL; Pereira DM; Borralho PM; Rodrigues CM; Castro RE
    Mol Cell Biol; 2014 Mar; 34(6):1100-20. PubMed ID: 24421392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of miR-34a/SIRT1/p53 signaling contributes to cochlear hair cell apoptosis: implications for age-related hearing loss.
    Xiong H; Pang J; Yang H; Dai M; Liu Y; Ou Y; Huang Q; Chen S; Zhang Z; Xu Y; Lai L; Zheng Y
    Neurobiol Aging; 2015 Apr; 36(4):1692-1701. PubMed ID: 25638533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
    Wang X; Dong K; Gao P; Long M; Lin F; Weng Y; Ouyang Y; Ren J; Zhang H
    Cancer Biother Radiopharm; 2013 Feb; 28(1):45-50. PubMed ID: 23036084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.
    Ye Z; Fang J; Dai S; Wang Y; Fu Z; Feng W; Wei Q; Huang P
    Cancer Lett; 2016 Jan; 370(2):216-21. PubMed ID: 26523671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
    Li X; Zhao H; Zhou X; Song L
    Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1/mTOR signal pathway.
    Kou X; Liu X; Chen X; Li J; Yang X; Fan J; Yang Y; Chen N
    Oncotarget; 2016 Nov; 7(46):74484-74495. PubMed ID: 27780933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
    Herbert KJ; Cook AL; Snow ET
    Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells.
    Akao Y; Noguchi S; Iio A; Kojima K; Takagi T; Naoe T
    Cancer Lett; 2011 Jan; 300(2):197-204. PubMed ID: 21067862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop.
    Xia C; Shui L; Lou G; Ye B; Zhu W; Wang J; Wu S; Xu X; Mao L; Xu W; Chen Z; Liu Y; Zheng M
    Sci Rep; 2017 Jun; 7(1):4396. PubMed ID: 28667294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.